Just imagine — a cancer treatment that is noninvasive and has no side effects. Ask anyone… there’s nothing like it! But John Kanzius knew there had to be a better way to treat cancer; better than chemotherapy – better than radiation therapy. He thought outside the box and countless others have joined the Kanzius Cancer Research Foundation (KCRF) in a quest to win the “War on Cancer.” Research for “the world’s most promising cancer treat-ment” comes with a price. Thank you for your generous support that has advanced laboratory outcomes to a new level.

“Our research is spreading across the medical and scientific world. We are honored to have a team of brilliant surgeons, scientists, chemists and engineers, from prestigious academic institutions, proving how effective the Kanzius Noninvasive Radiowave Cancer Treatment can be for patients,” said Mark Neidig executive director of KCRF. “It’s thrilling to see that these teams are persistent and their new published findings are always emerging and giving us hope.”

The following is a glimpse of what is currently underway in the laboratories:

University of Pittsburgh Medical Center (UPMC)Dr. David A. Geller, MD is leading a study to destroy inoperable liver cancer in a noninvasive manner. Dr. Geller, principal investigator of the Kanzius study at UPMC, is the Richard L. Simmons professor of surgery at the University of Pittsburgh School of Medicine and Co-Director of the UPMC Liver Cancer Center.

This study is highly relevant today as over 20,000 patients develop primary liver cancer each year in the United States. Another 80,000 patients develop colorectal cancer that spreads to the liver each year. Because 75% of these tumors are inoperable at the time of diagnosis, these patients could truly benefit from the Kanzius Noninvasive Radiowave Cancer Treatment.

Insidethis issue

Kanzius Cancer Research Foundation Fall 2011 Vol. 2, Issue 3

130 West 8th Street • Erie, PA 16501 • 814.480.5776 • www.Kanzius.org

The MISSION of the Kanzius Cancer Research Foundation is to create national and global awareness of the potentials of the Kanzius Noninvasive Radiowave Cancer Treatment and to raise funds to help accelerate the speed at which research progresses through human trials.

Researching the world’s most promising cancer treatment

Researching The World’s Most Promising Cancer TreatmentA look at what is currently underway in laboratories across the country, proving how effective the Kanzius Noninvasive Radiowave Cancer Treatment can be for patients.

Minutes MatterLearn how your donations can fund important minutes of promising cancer research through the Kanzius Foundation and how EVERY dollar brings the Kanzius Noninvasive Radio-wave Cancer Treatment closer to human trials.

Faces of the Fight: Jim BoldingRead how a world record-hold-ing athlete with “a huge heart, a quick wit, and a love for life and friends” demonstrated a generosity that will enable us to continue the fight to find “a better way” to treat cancer.

Since last year, the UPMC team has focused on the properties that heat nanoparticles in solution and collaborated with Dr. Hong Koo Kim, co-director of the Petersen Institute of NanoScience and Engineering at the University of Pittsburgh.

“Our team is dedicated to destroying cancer cells in vitro and in vivo to prove the Kanzius Noninvasive Radiowave Cancer Treatment,” said Dr. Geller. “Our research has come so far in the past year. I look forward to developing our findings and building on these remarkable studies.”

His results have demonstrated that further investigative research is necessary. Therefore, Dr. Geller will continue collaborations with Dr. Kim to further investigate the physical chemistry properties that allow radiowaves to heat the nanoparticles and work actively to join gold nanoparticles with liver cancer-specific antibodies.

The University of Texas M.D. Anderson Cancer Center, Houston (MD Anderson)For patients at war with pancreatic cancer or liver cancer, over 96% of those diagnosed will lose their battle as a result of the cancer. The Kanzius/Curley lab at MD Anderson is focusing their efforts on these two malignancies to a much greater degree.

Continued on page 2.

The Kanzius Research Team at UPMC

From the Executive Director Mark A. Neidig, Sr.

MNeidig@Kanzius.org

Kanzius Cancer Research Foundation • 130 West 8th Street • Erie, PA 16501

Are you pressured by the clock? Whether it’s the countdown at the final four championship game, stand-ing at the bedside of a loved one battling cancer or putting the final touches on a project due at work…we can all relate to the passing of time. And don’t we always add…“If I could just have five more minutes?” The same is true in research. It takes so much time and money to validate outcomes. I hope you will take a serious look at your clock today and set some time aside for the world’s most promising cancer treatment research.

Continued from page 1.

As validated in several peer-reviewed journals, “we now know gold nanoparticles are the facilitator for heating up cancer cells and from this we changed our scientific approach as well as started investigating the use of silver and carbon nanoparticles within our research,” said Dr. Steven A. Curley, M.D., F.A.C.S., professor of surgical oncology, Charles B. Barker chair in surgery, and chief of gastrointestinal tumor surgery at The University of Texas MD Anderson Cancer Center in Houston, Texas, and lead investigator of the Kanzius Research Project.

In addition, the Kanzius/Curley lab has revealed groundbreaking medical discoveries that were published over the past year in several medical journals. The team has hired new research staff and plans to add more equipment to the lab. New studies have been initiated by Dr. Curley’s team on human prostate cancer, breast cancer and leukemia as well.

“Our team stays positive because our findings are promising and our research continues to develop each day,” said Dr. Curley. “We keep a picture of John Kanzius right outside our labs reminding us to continue his fight and this continues our momentum.”

University of California, Davis (UC Davis)Recently, KCRF began collaborating with a team of biomedical engineers at UC Davis. They published a manuscript this past July in IEEE, the world’s largest professional association journal dedicated to advancing technological innovation and excellence for the benefit of humanity, demonstrating that cancer cells are indeed killed when incubated with gold nanoparticles and exposed to certain levels of radiofrequency electromagnetic fields. Building on John Kanzius’ vision, the team developed a delivery system capable of performing the Kanzius Noninvasive Radiowave Cancer Treatment.

“Though our most recent work is preliminary, we have some unique experimental and theoretical insights that build upon John Kanzius’ initial vision to noninvasively treat cancer,” said Dustin Kruse, Ph.D., assistant research engineer at UC Davis. “We have developed a systemic delivery system of nanoparticles to cancer cells that validate the Kanzius Noninvasive Radiowave CancerTreatment.”

Dr. Peter Depowski, pathologist, vice president of the KCRF Board of Directors and chair of the KCRF Research Grants Committee adds, “this is a great addition to the growing body of literature regarding radiowave treatment but also independently confirms the potential of killing cancer using the Kanzius method, moving us closer to a potential new cancer therapy.”

There is a better way and research is validating the Kanzius Noninvasive Radiowave Cancer Treatment. This is where the promise lies! To ensure that the medical institutions and their teams researching the world’s most promising cancer treatment have the funds needed to keep the momentum moving forward, we need your continued, generous support.

Have you ever stopped to think what you can accomplish in

a minute? You can send a text message, take

out the garbage, kiss your sweetheart, water the house- plants, buy a cup of coffee or make your to-do list

for the day.

All of these tasks are important, but what if you could help stop the debilitating side effects of cancer treatments? Would you?

This year, it will take $2 million to make our research possible. Spreading these expenses over a 40 hour week for 52 weeks – an average minute costs $20. Sadly, during that minute, one life is lost to cancer.

Imagine the impact you can have by funding minutes of promising cancer research through the Kanzius Foundation. Every gift, no matter the size, is important. Every dollar brings the Kanzius Noninvasive Radiowave Cancer Treatment closer to human trials. How many minutes can you fund today to bring this treatment closer to reality?

Donate now. Your minutes matter!

The Kanzius Research Team at MD Anderson

kanzius.org

Some of you may remember the two NCAA championships—for the 400 meter and 440 yard hurdles—Jim won while attending Oklahoma State University in the 1970s. Or, perhaps you associate his name with the world record in the 440 yard hurdle that he set in 1974 and which still stands today. His children and extended family remember him as a man who lived his life “…as a wonderful son…a protective brother…a loving and caring husband…a devoted father…and a loyal friend.”

Jim’s brother, Jeff, said in his eulogy, “Jim was a fierce competitor, and like all great athletes, had the ability to push through the pain. Jim never thought of himself as special. Just as he lived his life, he dealt with his disease and death in the same way, selflessly. He was courageous and never complained. When his doctor told Jim that his cancer had returned and there was nothing else they could do for him, Jim planned a trip to Kauai.”

Jim learned about the Kanzius research and the KCRF while being treated at MD Anderson in Houston, Texas. Jim’s cancer ended his life much too soon. But, Jim’s selflessness and fighting spirit showed, even in his final acts, a generosity that will enable us to continue the fight to find “a better way” to treat cancer.

Nearly 2/3 of the donations sent to the Kanzius Foundation are

made in memory of a loved one. If your loved one chooses to name us as a recipient of

memorial gifts, please contact our office. We can assist your funeral director with envelopes and informational brochures

about the world’s most promising cancer research

that we are funding.

Jim Bolding 1949-2011 KANZIUS.ORG

Spread the Wave to Cure Cancer • 814.480.5776 • www.Kanzius.org

KANZIUS.ORG

Survey ResultsWe’ve all been touched by cancer in some way. Faces of the Fight are the personal stories of cancer patients, family members and their loved ones who are fighting for a better way of treating cancer.

Four different images for this initiative passed the vetting of marketing experts, focus groups and the Kanzius Foundation’s database of constituents and online community. Nearly 68% selected the winning image as most representative of the purpose of the initiative. The absence of actual faces allows individuals to place themselves in this image. As with each new Kanzius brand, be watching for new applications being rolled out. Thank you for participating.

FIGHTFACES ofthe

kanzius.org

14% 10% 8%

On July 31, Jim Bolding of Stillwater, Okla., lost his six-and-a-half year battle with colorectal cancer that metastasized into the liver. Jim’s name was unknown to the Kanzius Cancer Research Foundation before that date, but as the Founda-tion began to receive donations in Jim’s memory, they reached out to his family to say thank you. They soon learned about this gentle and caring man who is described as having “a huge heart, a quick wit, and a love for life and friends” along with great pride in his children, Taylor and Tatum.

68%

On August 2nd, in just 12 hours during the

Erie Gives campaign, YOU helped us receive

$22,439.19 — making KCRF the charity with

the largest number of donors.

THANK YOU!

We could not research “the world’s most

promising cancer treatment” without

your support.

Spread the Wave to Cure Cancer • 814.480.5776 • www.Kanzius.org

Please help us maintain up-to-date records and save money. Did you receive a duplicate copy of this newsletter? Is your mailing information correct? Would you like a copy sent to a friend? If so, please let us know by returning the supplied envelope or visit our website and click “Contact Us.”

Nonprofit Org.U.S. Postage

P A I DPermit No. 288

Erie, PA

The Kanzius Cancer Research Foundation is a 501(c)(3) nonprofit organization with EIN Tax ID# 26-1790100

You’re invited!Are you a college sports fanatic AND a supporter of the Kanzius Foundation? If so, consider hosting a Final Cure Party on April 2, 2012 during the NCAA Men’s basketball championship game!

Hosting a party will be a win-win situation — it’s an easy way to increase awareness about the Kanzius Noninvasive Radiowave Cancer Treatment…not to mention having a great time with family and friends while rooting for your favorite team!

We’ve made it easy, so you will be enjoying the game before you know it! On our web site, there are handouts for you to use, as well as a video you can show before the game. We have provided suggestions for making the event a success, but … the sky is the limit! Use your imagination!

While no one will know who the actual winner of the game is until the final buzzer, one thing is for certain … if you decide to be a fan of KCRF and host a Final Cure Party, everyone will be a winner!

Visit www.finalcureparty.com to find all the information you need.

www.Kanzius.org • 814.480.5776130 West 8th Street • Erie, PA 16501

KANZIUS04.02.12

KCRF is holding a Holiday Card design contest. Children of any age can enter, and the top five designs will be available in a limited edition set of 10 cards (two of each). For more details, or to preorder your cards, visit Kanzius.org/cards or call 814.480.5776.

Just in time for the Holidays!